EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus

Ahmed Hassan, Menna A Keshk, Mohamed Reyad, Nourhan Ahmed, Omar Nassar, Aisha Siraj, Salem Badr, Sherif Eltawansy, Anoop Misra, Muhammed Amir Essibayi, Ahmed Y Azzam, Mahmoud Nassar und 1 weitere

ASIDE Internal Medicine · 2025

DOI: 10.71079/aside.im.08252522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASIDE Internal Medicine, 2025. Verfasst von Ahmed Hassan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Suez Medical Complex, Ministry of Health and Population, Suez, Egypt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 2 diabetes mellitus (T2DM) is associated with dyslipidemia and significantly increased cardiovascular risk, making lipid-modifying therapy a crucial preventive intervention in these patients. Despite clear guidelines recommending statin therapy for both primary and secondary prevention, real-world prescription routines and practices show gaps in clinical care. We aimed to evaluate the rates and patterns of lipid-modifying therapy under prescription among T2DM patients across U.S. healthcare facilities.

Methods

We conducted a retrospective observational analysis using the TriNetX US Collaborative Network database, including data from 69 healthcare organizations throughout the United States. Patients with T2DM patients aged 40-75 years were included in our cohort. Under-prescription rates were calculated and analyzed across demographic subgroups using standardized protocols within the TriNetX platform.

Results

Among 5,007,910 T2DM patients, we observed significant statin under-prescription rates. Our analysis showed a prescription rate of 55.1% for statins in eligible patients with T2DM.

Conclusions

Our findings revealed a significant under-prescription of lipid-modifying therapy in T2DM patients. The universal nature of under-prescription suggests barriers to guideline implementation. These results underscore the urgent need for systematic interventions, including automated identification systems, standardized protocols, and optimized provider education to improve cardiovascular risk management in patients with T2DM.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular DiseaseDiabetes MellitusLipid-Modifying DrugsRetrospective observational analysisStatin

Autor:innen und Institutionen

  • Department of Cardiology, Suez Medical Complex, Ministry of Health and Population, Suez, Egypt.
  • Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Cardiology Department, Banner University Medical Center, Phoenix, AZ, United States.
  • Department of Nephrology, Suez Medical Complex, Ministry of Health and Population, Suez, Egypt.
  • Champlain Valley Union High School, Hinesburg, VT, United States.
  • MetroHealth Medical Center, Case Western Reserve University, Ohio, United States.

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Hassan, A., Keshk, M. A., Reyad, M., Ahmed, N., Nassar, O., Siraj, A., Badr, S., Eltawansy, S., Misra, A., Essibayi, M. A., Azzam, A. Y., Nassar, M., & Hakim, D. (2025). Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus. ASIDE Internal Medicine. https://doi.org/10.71079/aside.im.08252522

Vancouver

Hassan A, Keshk MA, Reyad M, Ahmed N, Nassar O, Siraj A, et al. Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus. ASIDE Internal Medicine. 2025. doi:10.71079/aside.im.08252522

BibTeX
@article{Hassan2025,
  author = {Hassan, Ahmed and Keshk, Menna A and Reyad, Mohamed and Ahmed, Nourhan and Nassar, Omar and Siraj, Aisha and Badr, Salem and Eltawansy, Sherif and Misra, Anoop and Essibayi, Muhammed Amir and Azzam, Ahmed Y and Nassar, Mahmoud and Hakim, Diaa},
  title = {Bridging the Gap between Evidence and Practice: Nationwide Retrospective Analysis of Lipid-Modifying Therapy Prescription Patterns in 5 Million Patients with Type 2 Diabetes Mellitus},
  journal = {ASIDE Internal Medicine},
  year = {2025},
  doi = {10.71079/aside.im.08252522}
}
Kostenlos starten →